Overcoming interferon (IFN)-γ resistance ameliorates transforming growth factor (TGF)-β-mediated lung fibroblast-to-myofibroblast transition and bleomycin-induced pulmonary fibrosis
- PMID: 33285108
- DOI: 10.1016/j.bcp.2020.114356
Overcoming interferon (IFN)-γ resistance ameliorates transforming growth factor (TGF)-β-mediated lung fibroblast-to-myofibroblast transition and bleomycin-induced pulmonary fibrosis
Abstract
Abnormal activation of transforming growth factor (TGF)-β is a common cause of fibroblast activation and fibrosis. In bleomycin (BLM)-induced lung fibrosis, the marked expression of phospho-Src homology-2 domain-containing phosphatase (SHP) 2, phospho-signal transducer and activator of transcription (STAT) 3, and suppressor of cytokine signaling (SOCS) 3 was highly associated with pulmonary parenchymal lesions and collagen deposition. Human pulmonary fibroblasts differentiated into myofibroblasts exhibited activation of SHP2, SOCS3, protein inhibitor of activated STAT1, STAT3, interleukin (IL)-6, and IL-10. The significant retardation of interferon (IFN)-γ signaling in myofibroblasts was revealed by the decreased expression of phospho-STAT1, IFN-γ-associated genes, and IFN-γ-inducible protein (IP) 10. Microarray analysis showed an induction of fibrotic genes in TGF-β1-differentiated myofibroblasts, whereas IFN-γ-regulated anti-fibrotic genes were suppressed. Interestingly, BIBF 1120 treatment effectively inhibited both STAT3 and SHP2 phosphorylation in TGF-β1-differentiated myofibroblasts and BLM fibrotic lung tissues, which was accompanied by suppression of fibroblast-myofibroblast transition. Moreover, the combined treatment of BIBF 1120 plus IFN-γ or SHP2 inhibitor PHPS1 plus IFN-γ markedly reduced TGF-β1-induced α-smooth muscle actin and further ameliorated BLM lung fibrosis. Accordingly, myofibroblasts were hyporesponsiveness to IFN-γ, while blockade of SHP2 contributed to the anti-fibrotic efficacy of IFN-γ.
Keywords: Fibrosis; IFN-γ; Myofibroblasts; SHP2; TGF-β.
Copyright © 2020 Elsevier Inc. All rights reserved.
Similar articles
-
Curdione ameliorates bleomycin-induced pulmonary fibrosis by repressing TGF-β-induced fibroblast to myofibroblast differentiation.Respir Res. 2020 Feb 19;21(1):58. doi: 10.1186/s12931-020-1300-y. Respir Res. 2020. PMID: 32075634 Free PMC article.
-
Arsenic trioxide inhibits transforming growth factor-β1-induced fibroblast to myofibroblast differentiation in vitro and bleomycin induced lung fibrosis in vivo.Respir Res. 2014 Apr 24;15(1):51. doi: 10.1186/1465-9921-15-51. Respir Res. 2014. PMID: 24762191 Free PMC article.
-
Emodin alleviates bleomycin-induced pulmonary fibrosis in rats.Toxicol Lett. 2016 Nov 16;262:161-172. doi: 10.1016/j.toxlet.2016.10.004. Epub 2016 Oct 4. Toxicol Lett. 2016. PMID: 27717887
-
Genesis of the myofibroblast in lung injury and fibrosis.Proc Am Thorac Soc. 2012 Jul;9(3):148-52. doi: 10.1513/pats.201201-011AW. Proc Am Thorac Soc. 2012. PMID: 22802289 Free PMC article. Review.
-
METTL3-mediated m6A RNA methylation induces the differentiation of lung resident mesenchymal stem cells into myofibroblasts via the miR-21/PTEN pathway.Respir Res. 2023 Nov 28;24(1):300. doi: 10.1186/s12931-023-02606-z. Respir Res. 2023. PMID: 38017523 Free PMC article. Review.
Cited by
-
C-phycocyanin reinforces autophagy to block pulmonary fibrogenesis by inhibiting lncIAPF biogenesis.Arch Pharm Res. 2024 Jul 22. doi: 10.1007/s12272-024-01508-y. Online ahead of print. Arch Pharm Res. 2024. PMID: 39039254
-
Tumor-mesothelium HOXA11-PDGF BB/TGF β1-miR-181a-5p-Egr1 feedforward amplifier circuity propels mesothelial fibrosis and peritoneal metastasis of gastric cancer.Oncogene. 2024 Jan;43(3):171-188. doi: 10.1038/s41388-023-02891-4. Epub 2023 Nov 21. Oncogene. 2024. PMID: 37989866 Free PMC article.
-
Protective effects and mechanism of curcumin in animal models of pulmonary fibrosis: a preclinical systematic review and meta-analysis.Front Pharmacol. 2023 Oct 13;14:1258885. doi: 10.3389/fphar.2023.1258885. eCollection 2023. Front Pharmacol. 2023. PMID: 37900163 Free PMC article.
-
SHP2 promotes sarcoidosis severity by inhibiting SKP2-targeted ubiquitination of TBET in CD8+ T cells.Sci Transl Med. 2023 Sep 13;15(713):eade2581. doi: 10.1126/scitranslmed.ade2581. Epub 2023 Sep 13. Sci Transl Med. 2023. PMID: 37703351
-
NT-3 Combined with TGF-β Signaling Pathway Enhance the Repair of Spinal Cord Injury by Inhibiting Glial Scar Formation and Promoting Axonal Regeneration.Mol Biotechnol. 2024 Jun;66(6):1484-1495. doi: 10.1007/s12033-023-00781-4. Epub 2023 Jun 15. Mol Biotechnol. 2024. PMID: 37318740 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous